Clinical Trial Update: Dexamethasone for Ureteral STent Symptoms (DUSTS) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial (DUSTS) is evaluating dexamethasone to treat ureteral stent-related symptoms; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ureteral Stent-related Symptoms

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Ureteral Stent-Related Symptom | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING